DCM Shriram Industries Ltd
DCMSRINDDCM Shriram Industries Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: Domestic institutions moved +4.9 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced.
The price is in a downtrend (51 weeks in) while the P/E sits at the 99th percentile of its own 10-year range. Underneath, the last four quarters read deteriorating — profit −113.6% year on year, and 144% of the last 3 years' profit arrived as cash. What settles it: whether the register turns back in the story’s favour.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
DCM Shriram Industries Ltd trades at ₹38.4, in a downtrend and 51 weeks into that stage. That is −14.1% against its own 200-day average. It sits at 3% of a 52-week range of ₹38 to ₹47. On relative strength it has no relative-strength read yet.
Today the stock is in a downtrend — week 51 of stage 4, confirmed. At ₹38.4 it trades −14.1% versus its 200-day average and sits at 3% of its 52-week range (₹38–₹47).
Against the market, two honest reads. Cumulative: over the last 1 months the stock moved −6% while the NIFTY 500 moved −2% — behind the index over the full window. Recent form: no trailing-13-week read yet — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
DCM Shriram Industries Ltd trades at 8.2× P/E, about the priciest it has ever traded. Its long-run median P/E is 3.5×, measured across 10.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 8.2× is about the priciest it has ever traded, against a long-run median of 3.5× measured over 10.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
At its price on 13 June 2026, DCM Shriram Industries Ltd was priced for profit growth of about 1.1% a year. Profit itself has compounded 30.6% a year over the past 10 years. The market pays that at 8.2× P/E, the 99th percentile of its own 10-year range.
What the two numbers say together. The multiple is full against its own past, and the growth the price is paying for is below what this company has actually delivered. Both readings sit on the same earnings, so they are one reading rather than two.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements. Every other number on this page is read off the live quote.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
DCM Shriram Industries Ltd reads as deteriorating on its fundamental arc. Deteriorating — revenue and profit growth are shrinking (revenue growth −1.2% latest (single-quarter readings) against +9.0% at its 12-quarter best), ROCE holding at 14.0%. The read is built from 9 quarters across 3 curves, on partial evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −1.5% | −1.1% | +2.7% | +4.7% |
| Profit | −12.2% | +15.2% | +1.0% | +30.6% |
| EPS | −12.1% | +15.3% | +1.1% | +31.2% |
4-Factor Sector Score
43.7/100 — rank 20 of 20 in Sugar · 48% evidence confidence · provisional, ranked below fully-evidenced peers
DCM Shriram Industries Ltd scores 43.7 out of 100 against the 20 companies it is compared with in Sugar, ranking 20. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 12.5 + 14.6 + 8.8 + 7.8 = 43.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
DCM Shriram Industries Ltd reported ₹527 Cr of revenue in the Sep 25 quarter, −1.2% year on year. Over 10 years it has compounded at 4.7% a year. The last full year, FY25, came in at ₹2,052 Cr. The last four reported quarters add to ₹1,990 Cr.
FY25 revenue came in at ₹2,052 Cr (−1.5% on the year), capping 10 years at 4.7% compound. The latest quarter (Sep 25) printed ₹527 Cr, −1.2% year on year.
Pace check: the last four quarters averaged −3.4% growth against the decade's 4.7% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −3.7% over the last 4 quarters against −5.1%/yr over the last 8 — stabilising; TTM profit −50.0% vs −18.0%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
DCM Shriram Industries Ltd's operating margin is 1.8% in the Sep 25 quarter, −6.8 percentage points against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged 5.0% to 13.0%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is 1.8%, −6.8 pp against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged 5.0%–13.0%.
🚨 Why the margin moved: operating margin went −6.8 pp year on year while gross margin went −13.0 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
DCM Shriram Industries Ltd posted a net loss of ₹3.1 Cr in the Sep 25 quarter. Full-year FY25 profit was ₹101 Cr. The 10-year compound rate is 30.6%. That loss is 0.6% of the quarter's revenue. The same quarter a year earlier earned ₹22.9 Cr. 1 of the last 12 reported quarters were loss-making.
Sep 25 profit was ₹−3.1 Cr, −113.6% year on year. On the full year, FY25 printed ₹101 Cr (−12.2%), and the 10-year compound rate is 30.6%.
🚨 Why profit moved: revenue contributed −1.2% and the margin −6.8 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −54.4% vs revenue −3.4%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 144% of DCM Shriram Industries Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was ₹152 Cr of operating cash against ₹101 Cr of profit. After ₹71.0 Cr of capital spending, ₹81.0 Cr was left as free cash.
FY25: operating cash of ₹152 Cr against reported profit of ₹101 Cr, leaving free cash of ₹81.0 Cr after ₹71.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 144% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 144%: the cash cycle stretched 29 days between FY20 and FY25 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
DCM Shriram Industries Ltd's cash conversion cycle runs 190 days in FY25, up from 161 days in FY20. Capital spending ran ₹163 Cr over the last 3 years. At FY25 sales of ₹2,052 Cr each day of that cycle holds about ₹5.6 Cr, so roughly ₹1,068 Cr sits inside the business at any moment.
FY25: debtors at 43 days, inventory at 236 days — roughly 7.8 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 190 days, looser than FY20's 161.
The full loop: cash goes out to suppliers and production on day 0; stock waits 236 days to sell; customers pay about 43 days after that; and suppliers themselves are paid at 89 days — netting out to the 190-day cycle.
In money terms: at FY25 sales of ₹2,052 Cr, each day of the cycle holds about ₹5.6 Cr — so the 190-day loop keeps roughly ₹1,068 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹163 Cr over the last 3 fiscal years against ₹115 Cr of depreciation — building somewhat ahead of wear-and-tear. Capital work-in-progress stands at ₹3.0 Cr (FY25) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
DCM Shriram Industries Ltd earns a ROCE of 14% in FY25. That is up from a trough of 9% in FY15. Return on invested capital clears the cost of that capital by −6.0 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 4.9% net margin on 0.89× asset turns.
FY25 ROCE is 14%, recovered from a FY15 trough of 9% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY25): 4.9% net margin × 0.89× asset turns × 2.57× balance-sheet leverage ≈ 11.2% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 6.0% − 12.0% = a −6.0 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
DCM Shriram Industries Ltd carries ₹534 Cr of borrowings against ₹899 Cr of equity in FY25, a debt-to-equity of 0.59. Operating profit covers the interest bill 6×. Over 5 years borrowings went from ₹613 Cr to ₹534 Cr. Capital spending ran ₹163 Cr across the last 3 of those years.
FY25: borrowings of ₹534 Cr against equity of ₹899 Cr — a debt-to-equity of 0.59. Operating profit covers the interest bill 6×. Over 5 years borrowings went from ₹613 Cr to ₹534 Cr while capital spending ran ₹163 Cr in just the last 3 — the build-out is being paid for out of cash, not debt.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions added 4.9 points of DCM Shriram Industries Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 12.7% of the company. Foreign institutions moved −0.8 points over the same window, to 1.2%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: +4.9 points over 8 quarters to 12.7%; Foreign institutions: −0.8 points over 8 quarters to 1.2%; Promoters: +0.0 points over 8 quarters to 50.1%.
Why the register moved: domestic institutions drove it (+4.9 points), absorbed on the other side by foreign institutions (−0.8 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
DCM Shriram Industries Ltd: the Z-score reads 2.13. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 2.13 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 2.13.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Andhra Sugars LtdANDHRSUGAR | 77.7/100Favorable setup87% evidence | TURNING | 32.1/35 Revenue 16.5% · PAT 100% · OPM change 3 pp 95% evidence | 15.3/25 ROCE 8.5% · OPM 12% 95% evidence | 13.1/20 P/E 11.7× · PEG — 50% evidence | 17.2/20 RS sector 21.7% · RS bench 25% · 1Y 29.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 32.1 + 15.3 + 13.1 + 17.2 = 77.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2DCM Shriram LtdDCMSHRIRAM | 59.5/100Mixed-positive evidence100% evidence | BASING | 24.9/35 Revenue 11.1% · PAT 100% · OPM change 0 pp 100% evidence | 14.3/25 ROCE 11.5% · OPM 9% 100% evidence | 17.0/20 P/E 11.7× · PEG 0.44 100% evidence | 3.3/20 RS sector -14.8% · RS bench -12.3% · 1Y -24.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.9 + 14.3 + 17 + 3.3 = 59.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -14.8% and the one-year return is -24.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3M.V.K. Agro Food Product LtdMVKAGRO | 58.0/100Thin evidence · provisional52% evidence | ASLEEP | 18.3/35 Revenue — · PAT — · OPM change 17 pp 32% evidence | 18.3/25 ROCE 14.4% · OPM 22% 95% evidence | 9.7/20 P/E 24.8× · PEG — 15% evidence | 11.7/20 RS sector 33.8% · RS bench -56.9% · 1Y -13.7%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.3 + 18.3 + 9.7 + 11.7 = 58 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Dhampur Sugar Mills LtdDHAMPURSUG | 56.5/100Mixed-positive evidence87% evidence | TURNING | 21.8/35 Revenue 1.3% · PAT 36.3% · OPM change 1.3 pp 95% evidence | 9.8/25 ROCE 6.4% · OPM 5.7% 95% evidence | 9.3/20 P/E 14.7× · PEG — 50% evidence | 15.6/20 RS sector 14.9% · RS bench 17.9% · 1Y 18.5%4 of 12 weeks ahead 100% evidence |
| Exact sum: 21.8 + 9.8 + 9.3 + 15.6 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Avadh Sugar & Energy LtdAVADHSUGAR | 53.1/100Mixed-positive evidence79% evidence | BREAKING OUT | 14.5/35 Revenue 4.2% · PAT -6.9% · OPM change 0.7 pp 71% evidence | 10.6/25 ROCE 6.8% · OPM 4.7% 95% evidence | 8.0/20 P/E 19.4× · PEG — 50% evidence | 20.0/20 RS sector 43.9% · RS bench 47.4% · 1Y 50%7 of 12 weeks ahead 100% evidence |
| Exact sum: 14.5 + 10.6 + 8 + 20 = 53.1 · Decision use: Price leads the evidence: RS versus the benchmark is 47.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 6Uttam Sugar Mills LtdUTTAMSUGAR | 52.3/100Mixed-positive evidence74% evidence | TURNING | 16.7/35 Revenue 7.8% · PAT -7.6% · OPM change -3.7 pp 95% evidence | 15.3/25 ROCE 11.5% · OPM 4.3% 95% evidence | 11.2/20 P/E 11.5× · PEG — 15% evidence | 9.1/20 RS sector -9.1% · RS bench 8.4% · 1Y 9.7%3 of 10 weeks ahead 70% evidence |
| Exact sum: 16.7 + 15.3 + 11.2 + 9.1 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Dhampur Bio Organics LtdDBOL | 52.2/100Mixed-positive evidence72% evidence | TURNING | 21.6/35 Revenue 8% · PAT 100% · OPM change -0.1 pp 71% evidence | 7.3/25 ROCE 5% · OPM 1.7% 95% evidence | 9.5/20 P/E 31.1× · PEG — 15% evidence | 13.8/20 RS sector 18.6% · RS bench 21.5% · 1Y 49.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 7.3 + 9.5 + 13.8 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Triveni Engineering and Industries LtdTRIVENI | 51.1/100Mixed-positive evidence82% evidence | TURNING | 19.2/35 Revenue 4% · PAT 29.1% · OPM change 1 pp 95% evidence | 9.9/25 ROCE 6.8% · OPM 3.4% 76% evidence | 6.6/20 P/E 22.4× · PEG — 50% evidence | 15.4/20 RS sector 11.1% · RS bench 14.3% · 1Y 31.1%4 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 9.9 + 6.6 + 15.4 = 51.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Dalmia Bharat Sugar & Industries LtdDALMIASUG | 50.9/100Mixed-positive evidence100% evidence | TURNING | 7.2/35 Revenue -5.2% · PAT -44.1% · OPM change -4.4 pp 100% evidence | 11.5/25 ROCE 8.2% · OPM 5.1% 100% evidence | 14.3/20 P/E 16.7× · PEG 0.55 100% evidence | 17.9/20 RS sector 19.3% · RS bench 22.3% · 1Y 19.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 7.2 + 11.5 + 14.3 + 17.9 = 50.9 · Decision use: Price leads the evidence: RS versus the benchmark is 22.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 10EID Parry (India) LtdEIDPARRY | 50.0/100Mixed-positive evidence76% evidence | BASING | 17.9/35 Revenue 15.7% · PAT -38.9% · OPM change -1 pp 95% evidence | 17.9/25 ROCE 17% · OPM 8% 76% evidence | 9.7/20 P/E 17× · PEG — 50% evidence | 4.5/20 RS sector -20.5% · RS bench -15.9% · 1Y -30.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.9 + 17.9 + 9.7 + 4.5 = 50 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Balrampur Chini Mills LtdBALRAMCHIN | 48.8/100Mixed-negative evidence100% evidence | BREAKING OUT | 16.1/35 Revenue 15% · PAT -11.2% · OPM change -2 pp 100% evidence | 12.6/25 ROCE 9.3% · OPM 7% 100% evidence | 2.4/20 P/E 35.6× · PEG 2.21 100% evidence | 17.7/20 RS sector 19.7% · RS bench 22.9% · 1Y 14.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 12.6 + 2.4 + 17.7 = 48.8 · Decision use: Price leads the evidence: RS versus the benchmark is 22.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 12Magadh Sugar & Energy LtdMAGADSUGAR | 41.8/100Mixed-negative evidence79% evidence | TURNING | 8.0/35 Revenue -5.7% · PAT -46.9% · OPM change -5.8 pp 71% evidence | 9.1/25 ROCE 7.8% · OPM 0.2% 95% evidence | 9.6/20 P/E 14.8× · PEG — 50% evidence | 15.1/20 RS sector 4.2% · RS bench 7.1% · 1Y 3.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 8 + 9.1 + 9.6 + 15.1 = 41.8 · Decision use: Price leads the evidence: RS versus the benchmark is 7.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 13Zuari Industries LtdZUARIIND | 39.8/100Mixed-negative evidence66% evidence | BASING | 16.3/35 Revenue 9.7% · PAT 100% · OPM change -5.3 pp 71% evidence | 7.8/25 ROCE 5.5% · OPM 4.5% 95% evidence | 11.5/20 P/E 6.7× · PEG — 15% evidence | 4.2/20 RS sector -26.8% · RS bench -11% · 1Y -15.7%2 of 10 weeks ahead 70% evidence |
| Exact sum: 16.3 + 7.8 + 11.5 + 4.2 = 39.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Davangere Sugar Company LtdDAVANGERE | 37.7/100Mixed-negative evidence70% evidence | 14.7/35 Revenue 11.1% · PAT -22.3% · OPM change -6.9 pp 83% evidence | 10.3/25 ROCE 5.6% · OPM 10.1% 95% evidence | 8.5/20 P/E 58.6× · PEG — 15% evidence | 4.2/20 RS sector -25% · RS bench -12.6% · 1Y 9.4%0 of 6 weeks ahead to 2026-07-19 70% evidence | |
| Exact sum: 14.7 + 10.3 + 8.5 + 4.2 = 37.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Bannari Amman Sugars LtdBANARISUG | 37.4/100Mixed-negative evidence100% evidence | ASLEEP | 11.4/35 Revenue -7.6% · PAT 8% · OPM change -12 pp 100% evidence | 11.3/25 ROCE 9.3% · OPM -3% 100% evidence | 9.6/20 P/E 35.5× · PEG 1.75 100% evidence | 5.1/20 RS sector -8.6% · RS bench -5.9% · 1Y -8.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.4 + 11.3 + 9.6 + 5.1 = 37.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Godavari Biorefineries LtdGODAVARIB | 36.7/100Mixed-negative evidence72% evidence | BASING | 18.3/35 Revenue 7% · PAT 100% · OPM change -1 pp 71% evidence | 7.3/25 ROCE 6.5% · OPM 0.1% 95% evidence | 8.8/20 P/E 43.6× · PEG — 15% evidence | 2.3/20 RS sector -15.5% · RS bench -13.2% · 1Y -13.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 7.3 + 8.8 + 2.3 = 36.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Dwarikesh Sugar Industries LtdDWARKESH | 31.5/100Adverse evidence72% evidence | ASLEEP | 10.0/35 Revenue -4.8% · PAT -45.8% · OPM change -8 pp 71% evidence | 2.5/25 ROCE 4.6% · OPM -7% 95% evidence | 8.7/20 P/E 54.9× · PEG — 15% evidence | 10.3/20 RS sector -0.6% · RS bench 2% · 1Y 7%3 of 12 weeks ahead 100% evidence |
| Exact sum: 10 + 2.5 + 8.7 + 10.3 = 31.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Bajaj Hindusthan Sugar LtdBAJAJHIND | 30.4/100Adverse evidence85% evidence | BASING | 13.2/35 Revenue -1.9% · PAT 100% · OPM change -8.9 pp 74% evidence | 1.1/25 ROCE 3.1% · OPM -11% 100% evidence | 11.1/20 P/E 31.9× · PEG 1.32 100% evidence | 5.0/20 RS sector -21% · RS bench -9.4% · 1Y -23.9%4 of 11 weeks ahead 70% evidence |
| Exact sum: 13.2 + 1.1 + 11.1 + 5 = 30.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Shree Renuka Sugars LtdRENUKA | 23.3/100Adverse evidence71% evidence | BASING | 9.9/35 Revenue -5.1% · PAT -80% · OPM change 0.7 pp 74% evidence | 0.5/25 ROCE -3.1% · OPM -3.6% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 2.9/20 RS sector -19.8% · RS bench -17.5% · 1Y -23.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 9.9 + 0.5 + 10 + 2.9 = 23.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20DCM Shriram Industries Ltdthis pageDCMSRIND | 43.7/100Thin evidence · provisional48% evidence | 12.5/35 Revenue -3.7% · PAT -50% · OPM change -6.8 pp 45% evidence | 14.6/25 ROCE 13.7% · OPM 1.8% 71% evidence | 8.8/20 P/E 8.2× · PEG — 50% evidence | 7.8/20 RS sector — · RS bench -16.3% · 1Y — 25% evidence | |
| Exact sum: 12.5 + 14.6 + 8.8 + 7.8 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is DCM Shriram Industries Ltd's share price today?
DCM Shriram Industries Ltd trades at ₹38.4. The company is valued at ₹498 Cr. The stock sits at 3% of its 52-week range of ₹38–₹47, −14.1% versus its 200-day average. On the tape, the price is in a downtrend, 51 weeks in. — as of 14 August 2026.
What were DCM Shriram Industries Ltd's latest quarterly results?
DCM Shriram Industries Ltd reported revenue of ₹527 Cr and a net loss of ₹3.1 Cr for the Sep 25 quarter. Revenue fell 1.2% and profit fell 113.6% year on year. Earnings per share were ₹−0.36. The operating margin was 1.8%, 6.8 pp lower than a year earlier. — as of 14 August 2026.
What is DCM Shriram Industries Ltd's revenue?
DCM Shriram Industries Ltd reported revenue of ₹527 Cr in the Sep 25 quarter, −1.2% year on year. For the full FY25 fiscal year, revenue was ₹2,052 Cr (−1.5%). Over the last 10 years revenue compounded at 4.7% a year. — as of 14 August 2026.
What is DCM Shriram Industries Ltd's profit?
DCM Shriram Industries Ltd earned ₹−3.1 Cr of net profit in the Sep 25 quarter, −113.6% year on year. Full-year FY25 profit was ₹101 Cr. The operating margin ran 1.8% in the latest quarter. — as of 14 August 2026.
What is DCM Shriram Industries Ltd's market cap?
DCM Shriram Industries Ltd's market capitalisation is ₹498 Cr at a share price of ₹38.4. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is DCM Shriram Industries Ltd's P/E ratio?
DCM Shriram Industries Ltd trades at a P/E of 8.2×, at the 99th percentile of its own 10-year range, against a long-run median of 3.5×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does DCM Shriram Industries Ltd pay a dividend?
Yes — DCM Shriram Industries Ltd's dividend payout was 17% of profit in FY25, and it recorded a payout in each of its last 12 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 14 August 2026.
Is DCM Shriram Industries Ltd overvalued?
On its own history, DCM Shriram Industries Ltd looks expensive: its P/E of 8.2× sits at the 99th percentile of its 10-year range (long-run median 3.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.
Is DCM Shriram Industries Ltd growing?
Not right now — DCM Shriram Industries Ltd's latest numbers are shrinking: latest-quarter revenue −1.2% year on year, profit −113.6%, and the margin −6.8 pp at 1.8%. The 10-year compound rates are 4.7% (revenue) and 30.6% (profit). The earnings engine currently reads: deteriorating — as of 14 August 2026.
How is DCM Shriram Industries Ltd performing?
DCM Shriram Industries Ltd is in a downtrend, 51 weeks in. Its latest quarter's revenue fell 1.2% and profit fell 113.6% year on year. This describes what the data did, not a rating. — as of 14 August 2026.
What stage is DCM Shriram Industries Ltd in?
Deteriorating — revenue and profit growth are shrinking (revenue growth −1.2% latest (single-quarter readings) against +9.0% at its 12-quarter best), ROCE holding at 14.0%. The read comes from the last 12 quarters of growth (revenue growth −1.2% latest, profit growth −113.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 14 August 2026.
Is DCM Shriram Industries Ltd in an uptrend?
No — the price is in a downtrend (week 51 of stage 4), trading −14.1% versus its 200-day average and at 3% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Will DCM Shriram Industries Ltd's share price go up?
This page publishes no price forecast for DCM Shriram Industries Ltd. What it measures instead: the share price is ₹38.4, the price is in a downtrend 51 weeks in. Its P/E of 8.2× sits at the 99th percentile of its own 10-year range. — as of 14 August 2026.
Who owns DCM Shriram Industries Ltd?
Promoters hold 50.1% of DCM Shriram Industries Ltd, foreign institutions 1.2%, domestic institutions 12.7% and the public 35.9% (latest quarter). The biggest move on the register over the last two years: Domestic institutions added 4.9 points over 8 quarters. — as of 14 August 2026.
Does DCM Shriram Industries Ltd have too much debt?
It is moderate — DCM Shriram Industries Ltd's debt-to-equity is 0.59, and operating profit covers the interest bill 6×. FY25 borrowings were ₹534 Cr against equity of ₹899 Cr. Read the returns on this page with that leverage in mind — as of 14 August 2026.
What is DCM Shriram Industries Ltd's capex?
DCM Shriram Industries Ltd spent ₹163 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was ₹71.0 Cr, with ₹3.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is DCM Shriram Industries Ltd's cash flow?
DCM Shriram Industries Ltd generated ₹152 Cr of operating cash flow in FY25 and ₹81.0 Cr of free cash flow after ₹71.0 Cr of capital spending. Reported profit that year was ₹101 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 14 August 2026.
Is DCM Shriram Industries Ltd's profit real cash?
Yes — over the last 3 fiscal years, 144% of DCM Shriram Industries Ltd's reported profit arrived as operating cash. In FY25, operating cash was ₹152 Cr against reported profit of ₹101 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 14 August 2026.
How financially safe is DCM Shriram Industries Ltd?
On the balance sheet, the Z-score reads 2.13 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 14 August 2026.
Where is DCM Shriram Industries Ltd in its business cycle?
DCM Shriram Industries Ltd's FY25 operating margin was 10.0%, against a 12-year band of 5.0%–13.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 1.8%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What growth does DCM Shriram Industries Ltd's price assume?
At its price on 13 June 2026, DCM Shriram Industries Ltd was priced for profit growth of about 1.1% a year. Profit itself has compounded 30.6% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 14 August 2026.
What could break the DCM Shriram Industries Ltd story?
The sharpest disagreement: Domestic institutions moved +4.9 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is DCM Shriram Industries Ltd a stock worth studying right now?
This is not investment advice. The machine read: DCM Shriram Industries Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the register turns back in the story’s favour. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.